Insulin biosimilar (Sedico) |
|
Approved |
Sedico |
Insulin H bio R |
Egypt |
Diabetes Mellitus |
Sedico |
2013-02-01 |
Diabetes Mellitus |
Details
|
Oral insulin (Generex Biotechnology) |
|
Approved |
Generex Biotechnology Corp |
Oralin, Oralgen, Oral-lyn, Recosulin |
Ecuador |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
null |
2005-01-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insul 30/70 biosimilar (Popular Pharmaceuticals) |
|
Approved |
Popular Pharmaceuticals |
Insul 30-70 |
|
|
|
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational |
Details
|
Isophane Protamine Recombinant Human Insulin biosimilar (Popular Pharmaceuticals) |
|
Approved |
Popular Pharmaceuticals |
Insulin N |
Bangladesh |
Diabetes Mellitus |
Popular Pharmaceuticals |
2013-01-01 |
Diabetes Mellitus |
Details
|
Human insulin biosimilar (Square Pharmaceuticals) |
|
Approved |
Square Pharmaceuticals |
Ansulin |
Bangladesh |
Diabetes Mellitus |
Square Pharmaceuticals |
2013-01-01 |
Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin Injection (Shenzhen Kexing Biotech) |
|
Approved |
Shenzhen Kexing Biological Engineering Co Ltd |
苏泌啉恩 |
Mainland China |
Diabetes Mellitus |
Shenzhen Kexing Biological Engineering Co Ltd |
2003-02-24 |
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Getz Pharma) |
|
Approved |
Getz Pharma |
Basagine |
|
|
|
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Isophane Protamine Human Insulin(40R)(Tonghua Dongbao) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Recombinant human insulin (SciGen) |
|
Approved |
Generex Biotechnology Corp |
Recojet |
India |
Diabetes Mellitus |
null |
2004-12-01 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Shenzhen Kexing Biotech) |
|
Approved |
Shenzhen Kexing Biological Engineering Co Ltd |
苏泌啉, Su Bi Lin |
Mainland China |
Diabetes Mellitus |
Shenzhen Kexing Biological Engineering Co Ltd |
2002-06-10 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Hefei Tianmai Biotechnology) |
|
Approved |
Hefei Tianmai Biotechnology Development Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Hefei Tianmai Biotechnology Development Co Ltd |
2018-04-28 |
Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin (Hefei Tianmai Biotechnology) |
|
Approved |
Hefei Tianmai Biotechnology Development Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Hefei Tianmai Biotechnology Development Co Ltd |
2019-09-05 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glulisine |
HMR-1964 |
Approved |
Sanofi |
艾倍得, Apidra |
Mainland China |
Diabetes Mellitus |
Sanofi-Aventis Deutschland Gmbh |
2004-04-16 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Incepta Pharmaceuticals) |
|
Approved |
Incepta Pharmaceuticals Ltd |
|
Bangladesh |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Incepta Pharmaceuticals |
2012-08-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insulin human |
HR-1799 |
Approved |
Sanofi Deutschland |
Insulin Human Winthrop |
United States |
Diabetes Mellitus |
Baxter Healthcare Corp |
1997-02-21 |
Diabetic Ketoacidosis; Diabetic Coma; Diabetes Mellitus |
Details
|
Recombinant insulin (Horizon Pharma/Ibatech) |
|
Approved |
Savient Pharmaceuticals |
|
Poland |
Diabetes Mellitus, Type 1 |
null |
2002-07-01 |
Diabetes Mellitus, Type 1 |
Details
|
Human insulin biosimilar (MJ Biopharm) |
|
Approved |
Mj Biopharm Pvt |
Biosulin |
Russian Federation |
Diabetes Mellitus |
Mj Biopharm Pvt |
2005-12-01 |
Diabetes Mellitus |
Details
|
Insulin glargine |
U-300; Gla-100; Gla-300; Hoe-901; Hoe-71GT; HOE901-U300 |
Approved |
Sanofi |
来得时, Lantus, Toujeo, Lantus XR, Optisulin |
Japan |
Diabetes Mellitus |
Sanofi |
2000-04-20 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hyperglycemia; Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin (BIOTON) |
|
Approved |
Bioton |
|
Mainland China |
Diabetes Mellitus |
Bioton |
2013-03-29 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Incepta) |
|
Approved |
Incepta Pharmaceuticals Ltd |
Maxsulin |
Bangladesh |
Diabetes Mellitus |
Incepta Pharmaceuticals |
2012-01-01 |
Diabetes Mellitus |
Details
|
Recombinant insulin glargine (Gan & Lee) |
|
Approved |
Gan & Lee Biotech |
长秀霖, Basalin |
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2005-05-10 |
Diabetes Mellitus, Type 1; Diabetes Mellitus |
Details
|
Recombinant Human Insulin (Wanbang Pharma) |
|
Approved |
Jiangsu Wanbang Biopharmaceuticals |
|
Mainland China |
Diabetes Mellitus |
Jiangsu Wanbang Biopharmaceuticals |
2003-08-29 |
Diabetes Mellitus |
Details
|
Insulin human(Organon France) |
|
Approved |
Organon France |
|
EU |
Diabetes Mellitus |
Organon France |
1999-11-03 |
Diabetes Mellitus |
Details
|
Insulin biosimilar (Wockhardt) |
|
Approved |
Wockhardt |
Wosulin Pen Royale, Wosulin, Wosulin®-R, Wosulin Pen |
India |
Diabetes Mellitus, Type 1 |
Wockhardt |
2003-10-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus |
Details
|
Isophane Insulin |
|
Approved |
Jiangsu Wanbang Biopharmaceuticals |
万苏林 |
Mainland China |
Diabetes Mellitus |
Jiangsu Wanbang Biopharmaceuticals |
1997-01-01 |
Diabetes Mellitus |
Details
|
Insulin biosimilar (Harvest Moon Pharmaceuticals) |
|
Approved |
Harvest Moon |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Insulin biosimilar (Julphar) |
|
Approved |
Julphar (Gulf Pharmaceutical Industries) |
Julphar Insulin R |
Tunisia |
Diabetes Mellitus |
Julphar (Gulf Pharmaceutical Industries) |
2013-10-01 |
Diabetes Mellitus |
Details
|
Insulin lispro biosimilar (Sanofi) |
SAR-342434 |
Approved |
Sanofi |
Admelog |
United States |
Diabetes Mellitus, Type 2 |
Sanofi-Aventis U.S. Llc |
2017-07-18 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin detemir |
NN-304 |
Approved |
Novo Nordisk A/S |
诺和平, Levemir |
Japan |
Diabetes Mellitus |
Novo Nordisk A/S |
2004-06-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
长舒霖 |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2019-12-06 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Biocon/Mylan) |
MYL-1601D |
Approved |
Biocon |
|
EU |
Diabetes Mellitus |
Mylan Ire Healthcare Ltd |
2021-02-05 |
Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Sanofi) |
SAR-341402; SAR-Asp |
Approved |
Sanofi |
|
EU |
Diabetes Mellitus |
Sanofi-Aventis |
2020-06-25 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Zhuhai United) |
|
Approved |
Zhuhai United Laboratories Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Zhuhai United Laboratories Co Ltd |
2016-12-23 |
Diabetes Mellitus |
Details
|
Rosinsulin |
|
Approved |
Medsintez |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Wockhardt) |
|
Approved |
Wockhardt Bio Ag |
Glaritus, Glaritus Cart, Glaritus DispoPen |
India |
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Wockhardt |
2013-01-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (LG Life Sciences) |
|
Approved |
Lg Life Sciences Ltd |
Basugine |
|
|
|
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Insulin biosimilar (Popular Pharmaceuticals) |
|
Approved |
Popular Pharmaceuticals |
Insul R |
Bangladesh |
Diabetes Mellitus |
Popular Pharmaceuticals |
2013-01-01 |
Diabetes Mellitus |
Details
|
Isophane Insulin(Polish Society of Diabetology) |
|
Approved |
Polish Society of Diabetology |
|
|
|
|
|
Diabetes Mellitus |
Details
|
Insulin human (inhalation powder) |
SAR-439065 |
Approved |
Mannkind Corporation |
Afresa, Technosphere Insulin System, Afrezza |
United States |
Diabetes Mellitus, Type 2 |
Mannkind Corp |
2014-06-27 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Asthma; Pulmonary Disease, Chronic Obstructive |
Details
|
Isophane Protamine Human Insulin(30R)(Lilly) |
|
Approved |
Eli Lilly And Company |
|
|
|
|
|
|
Details
|
Insulin degludec/Insulin aspart |
NN-1045; NN-5401; NN-1250/Insulin aspart |
Approved |
Novo Nordisk A/S |
Ryzodeg, 诺和佳 |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
2012-12-25 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Recombinant human insulin (HEC Pharm) |
|
Approved |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
|
Mainland China |
Diabetes Mellitus |
Yichang Hec Changjiang Pharmaceutical Co Ltd |
2020-06-05 |
Diabetes Mellitus |
Details
|
Mixed Protamine Human Insulin(40R)(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖N |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
1999-01-01 |
Diabetes Mellitus |
Details
|
Insulin Aspart 50 |
|
Approved |
Novo Nordisk A/S |
诺和锐50 |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
2012-02-10 |
Diabetes Mellitus |
Details
|
30/70 Mixture Recombinant Human Insulin(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖30R |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2002-05-18 |
Diabetes Mellitus |
Details
|
50/50 Mixture Recombinant Human Insulin(Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖50R |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
2008-02-04 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (United Laboratories International Holdings) |
|
Approved |
Zhongshan Branch of Zhuhai United Laboratories Co Ltd |
优思灵, Uslin, 优思灵R |
Mainland China |
Diabetes Mellitus |
Zhongshan Branch of Zhuhai United Laboratories Co Ltd |
2009-11-25 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Tonghua Dongbao Pharmaceutical) |
|
Approved |
Tonghua Dongbao Pharmaceutical Co Ltd |
甘舒霖, 甘舒霖R |
Mainland China |
Diabetes Mellitus |
Tonghua Dongbao Pharmaceutical Co Ltd |
1998-01-01 |
Diabetes Mellitus |
Details
|
Insulin lispro protamine biosimilar(25R) (Gan & Lee) |
|
Approved |
Gan & Lee Biotech |
Prandilin25, 速秀霖25 |
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2014-05-09 |
Diabetes Mellitus |
Details
|
Recombinant human insulin (Biocon) |
|
Approved |
Biocon |
Insugen |
India |
Diabetes Mellitus |
Biocon |
2004-11-10 |
Diabetes Mellitus |
Details
|
Bacitracin |
|
Approved |
Pfizer Pharmaceuticals Ltd (China) |
|
|
Bacterial Infections |
Pfizer Pharmaceuticals Ltd (China) |
1945-01-01 |
Bacterial Infections |
Details
|
Ceritinib |
LDK-378; NVP-LDK378; NVP-LDK378-NX |
Approved |
Novartis Pharma Ag |
赞可达, Zykadia |
Mainland China |
Carcinoma, Non-Small-Cell Lung |
Novartis Europharm Ltd |
2014-04-29 |
Stomach Neoplasms; Glioblastoma; Pancreatic Neoplasms; Adenocarcinoma of Lung; Cholangiocarcinoma; Colorectal Neoplasms; Hepatic Insufficiency; Carcinoma, Squamous Cell; Lymphoma, Large-Cell, Anaplastic; Granuloma, Plasma Cell; Esophageal adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma |
Details
|
Insulin degludec/Liraglutide |
NN-9068 |
Approved |
Novo Nordisk A/S |
Xultophy, iDegLira |
Japan |
Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2014-09-18 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Zhuhai United Laboratories) |
|
Approved |
Zhuhai United Laboratories Co Ltd |
联邦优倍灵, Ublin |
Mainland China |
Diabetes Mellitus |
Zhuhai United Laboratories Co Ltd |
2021-07-12 |
Diabetes Mellitus |
Details
|
Insulin aspart biosimilar (Gan & Lee) |
|
Approved |
Gan & Lee Biotech |
Rapilin®30, Rapilin30, 锐秀霖30 |
Mainland China |
Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 |
Gan & Lee Biotech |
2020-06-05 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Details
|
Recombinant lispro insulin biosimilar (Gan & Lee) |
|
Approved |
Gan & Lee Pharmaceuticals |
|
Mainland China |
Diabetes Mellitus |
Gan & Lee Pharmaceuticals |
2006-01-19 |
Diabetes Mellitus |
Details
|
Imeglimin hydrochloride |
PXL-008; EMD-387008 |
Approved |
Merck KGaA, Darmstadt, Germany |
Twymeeg, ツイミーグ |
Japan |
Diabetes Mellitus, Type 2 |
Sumitomo Dainippon Pharma Co Ltd, Poxel Sa |
2021-06-23 |
Diabetes Mellitus, Type 2; Heart Diseases; Hepatic Insufficiency |
Details
|
Insulin glargine biosimilar (Biocon) |
MYL-1501D |
Approved |
Fujifilm Corp, Biocon Biopharmaceuticals, Mylan |
Semglee, Basalog |
United States |
Diabetes Mellitus |
Mylan Pharmaceuticals Inc |
2009-01-01 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin aspart |
NN-1218; INA-X14; Insulin X14 |
Approved |
Novo Nordisk A/S |
Novolog, NovoRapid, NovoLog FlexPen, NovoMix, Fiasp, 诺和锐, NovoRapid/NovoLog |
Japan |
Diabetes Mellitus |
Novo Nordisk A/S |
1999-09-07 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Rinsulin NPH (Geropharm) |
|
Approved |
Geropharm |
Rinsulin NPH |
Russian Federation |
Diabetes Mellitus |
Geropharm |
2012-10-01 |
Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin lispro biosimilar (Wanbang Biopharma) |
|
Approved |
Jiangsu Wanbang Biopharmaceuticals |
|
Mainland China |
Diabetes Mellitus |
Jiangsu Wanbang Biopharmaceuticals |
2022-01-25 |
Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(50R)(Novo Nordisk ) |
|
Approved |
Novo Nordisk A/S |
诺和灵50R |
Mainland China |
Diabetes Mellitus |
Novo Nordisk (China)Pharmaceuticals Co Ltd |
2019-11-27 |
Diabetes Mellitus |
Details
|
Isophane Protamine Recombinant Human Insulin(Novo Nordisk) |
|
Approved |
Novo Nordisk (China)Pharmaceuticals Co Ltd |
诺和灵N |
Mainland China |
Diabetes Mellitus |
Novo Nordisk (China)Pharmaceuticals Co Ltd |
2016-06-16 |
Diabetes Mellitus |
Details
|
Isophane Protamine Human Insulin(30R)(Novo Nordisk ) |
|
Approved |
Novo Nordisk A/S |
诺和灵30R |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
1999-07-28 |
Diabetes Mellitus |
Details
|
Insulin degludec |
NN-1250; Insulin-454 |
Approved |
Novo Nordisk A/S |
诺和达, Tresiba |
Mainland China |
Diabetes Mellitus, Type 2 |
Novo Nordisk A/S |
2012-09-28 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Lixisenatide/Insulin glargine |
HOE-901/AVE-0010 |
Approved |
Sanofi |
Soliqua, iGlarLixi, Suliqua |
EU |
Diabetes Mellitus, Type 2 |
Sanofi-Aventis |
2016-11-21 |
Diabetes Mellitus, Type 2 |
Details
|
Insulin lispro |
Pro-B29; LY-900027; LY-275585; Lys-B28; LYSPRO |
Approved |
Eli Lilly And Company |
Humalog, 优泌乐, Liprolog, Liumjev, Eglucent |
United States |
Diabetes Mellitus |
Eli Lilly And Company |
1996-04-30 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin glargine biosimilar (Lilly/Boehringer Ingelheim) |
LY-2963016; LY2963016-U-100; LY2963016-U-200 |
Approved |
Eli Lilly And Company, Boehringer Ingelheim Gmbh |
Abasria, Basaglar, Abasaglar, Rezvoglar |
United States |
Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 |
Eli Lilly And Company, Eli Lilly Cork Ltd |
2014-09-09 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin human (rDNA origin, Lilly) |
U-500R; S-3300; LY-041001 |
Approved |
Eli Lilly And Company |
Humulin R Pen, Humulin R Kwikpen, Humulin, Humulin R, 优泌淋R |
Japan |
Diabetes Mellitus |
Eli Lilly And Company |
1982-10-28 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus |
Details
|
Insulin human (rDNA origin, Novo Nordisk) |
NN-729 |
Approved |
Novo Nordisk A/S |
Insulatard, Actraphane, Mixtard, Novolin R, 诺和灵R |
Mainland China |
Diabetes Mellitus |
Novo Nordisk A/S |
1991-06-25 |
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Pulmonary Disease, Chronic Obstructive; Diabetes Mellitus |
Details
|